The microscopic diagnosis of cancer remains challenging. Recent data from our group within the French (nationwide) LymphoPath network shows that 20% diagnoses are inaccurate, with direct impact on patient care. Indeed, molecular techniques, not affordable for all pathology departments, have become critical final diagnosis. Currently, automated solutions could help pathologists diagnostic decisi...